Sunday, 20 September 2026European Markets

EKOPAK Stock Rises By 15% In The Last 5 Sessions

Loading stream...

(VIANEWS) - Shares of EKOPAK (BEL 20: EKOP.BR) rose by a staggering 15.61% in 5 sessions from €17.3 to €20.00 at 05:16 EST on Wednesday, following the last session's downward trend. BEL 20 is rising 0.79% to €3,534.85, after three successive sessions in a row of gains.

About EKOPAK

Ekopak NV designs, builds, finances, and operates industrial water processing solutions in Belgium, France, and internationally. It operates in two segments, Water-as-a-Service (WaaS) and Non-WaaS. The company offers cooling and feed, boiler, and process water treatment; corrosion control; ultra-filtration; legionella prevention; and disinfection. The company also supplies chemicals for internal water treatment for protection against corrosion of and deposits on steam boilers, hot water and heating circuits, drinking water circuits, and cooling towers and circuits. In addition, it designs, constructs, and optimizes various water treatment equipment, which include dosing stations, spraying systems, disinfection units, water softeners, decarbonation and demineralization units, reverse osmosis units, filtration units, iron and manganese removal units, activated carbon filtration units, and physico-chemical and biological wastewater stations, as well as online monitoring, and disinfection and acidity units. It serves to the chemical, food, medical, textile, and other industries. Ekopak NV was incorporated in 1997 and is headquartered in Tielt, Belgium.

Earnings Per Share

As for profitability, EKOPAK has a trailing twelve months EPS of €-0.15.

Volume

Today's last reported volume for EKOPAK is 6377 which is 56.2% above its average volume of 3352.

More news about EKOPAK (EKOP.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com